Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MBQ Pharma logo — Cancer will not spread throughout the body.

MBQ Pharma

Cancer will not spread throughout the body.

Founded 2018 Puerto Rico Puerto Rico 4 employees Biopharma, Biotechnology +2

General Information

Company Name MBQ Pharma
Founded Year 2018
Location Puerto Rico Puerto Rico +1
Employees 4
Industries Biopharma, Biotechnology, Health Care +1
Social

Get notified when MBQ Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MBQ Pharma

MBQ Pharma is a biopharmaceutical company based in Puerto Rico, founded in 2018. The company's focus is on developing innovative solutions to combat cancer, with the slogan "Cancer will not spread throughout the body." Their flagship product, MBQ-167, is a first-in-class nanomolar IC50 inhibitor for Rac and CDC42, targeting tumor growth inhibition and removal of pre-existing metastasis. The promising results in mouse tumor models, showing the inhibition of tumor growth and reversal of advanced metastasis, have garnered attention. Notably, the product has exhibited no toxicity findings in rats and dogs through GLP studies and in Safety Pharmacology studies, positioning it as a potentially safe and effective solution. With the IND for MBQ-167 scheduled by the end of 2021, MBQ Pharma presents an intriguing opportunity for investment in the biopharma, biotechnology, health care, and pharmaceutical industries. However, as of now, no specific information about recent investments or investors is available.

Taxonomy: Cancer treatment, Tumor growth inhibition, Metastasis prevention, Rac inhibitor, CDC42 inhibitor, MBQ-167, First-in-class inhibitor, Mouse tumor models, Toxicity studies, IND submission, Oncology, Therapeutics, GLP studies, Safety pharmacology, Drug development

No funding data available for MBQ Pharma yet.

Get notified when MBQ Pharma raises funding

MBQ Pharma Alternatives & Competitors

MBQ Pharma vs
ENB Therapeutics
ENB Therapeutics United States

Overcoming Immunotherapy resistance

Series A
6 employees
Biotechnology, Health and Wellness
MBQ Pharma vs
PhotonPharma
PhotonPharma United States

An immuno-oncology company unleashing the body to fight cancer

Seed
8 employees
MBQ Pharma vs
MetasTx LLC
MetasTx LLC United States

DRIVEN TO CREATE NOVEL THERAPEUTICS TO TREAT AND PREVENT METASTASIS OF CANCER

Pre Seed
6 employees
Manufacturing, Pharmaceutical

FAQ About MBQ Pharma

Cancer will not spread throughout the body.
MBQ Pharma was founded in 2018.
MBQ Pharma is headquartered in Puerto Rico.
MBQ Pharma operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
MBQ Pharma has approximately 4 employees.
Top alternatives and competitors to MBQ Pharma include ENB Therapeutics, PhotonPharma, MetasTx LLC, Batu Biologics, Inc., IV Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MBQ Pharma and ENB Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MBQ Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy